Profil
Mr. Nedal Safwat is on the Board of Directors at Gradientech AB. Mr. Safwat was previously employed as a VP & Head-Molecular Diagnostics North America by QIAGEN NV and a Chief Strategy Officer by Accelerate Diagnostics, Inc. He received his undergraduate degree from North Carolina State University and a doctorate degree from North Carolina State University.
Aktive Positionen von Nedal Safwat
| Unternehmen | Position | Beginn |
|---|---|---|
Gradientech AB
Gradientech AB Medical SpecialtiesHealth Technology Provides ultra-rapid antibiotic susceptibility testing services | Direktor/Vorstandsmitglied | 09.05.2023 |
Ehemalige bekannte Positionen von Nedal Safwat
| Unternehmen | Position | Ende |
|---|---|---|
| QIAGEN N.V. | Corporate Officer/Principal | 01.12.2024 |
| ACCELERATE DIAGNOSTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Nedal Safwat
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions | Health Technology |
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gradientech AB
Gradientech AB Medical SpecialtiesHealth Technology Provides ultra-rapid antibiotic susceptibility testing services | Health Technology |
















